---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-046293"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:35:26.448555+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q3 net loss $3.2M; guides down system-wide sales and new openings

## Summary
- Revenue $30.2M (+2% YoY); net loss $3.2M vs $716K loss in Q3 2023, including $3.8M impairment.
- Adjusted EBITDA fell to $2.4M from $2.9M; system-wide sales up 18% to $129.3M.
- Guidance cut: system-wide sales now $525-535M (prior $530-545M); new franchised openings 55-60 (prior 60-75).
- Total clinics 963 at Sept 30; sold 7 franchise licenses in Q3 vs 12 in Q3 2023.
- Unrestricted cash $20.7M; $20M credit facility available through Feb 2027.

## SEC filing metadata
- accession: 0001628280-24-046293
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/0001628280-24-046293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000162828024046293/jynt-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-046293
- JSON: https://secwatch.observer/filing/0001628280-24-046293.json
- Plain text: https://secwatch.observer/filing/0001628280-24-046293.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.